Welcome to our dedicated page for Stellus Capital Investment SEC filings (Ticker: SCM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Stellus Capital Investment's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Stellus Capital Investment's regulatory disclosures and financial reporting.
Stellus Capital Investment Corporation (NYSE: SCM) disclosed the results of its 17 June 2025 Annual Meeting in an 8-K filed on 20 June 2025 (Item 5.07).
Voting participation: 15,187,040 of 28,416,148 eligible shares (≈53.4%) were represented in person or by proxy.
Proposal 1 – Election of Directors:
- Dean D’Angelo: 14,468,514 FOR / 718,526 WITHHELD (≈95.3% support)
- William C. Repko: 13,693,643 FOR / 1,493,396 WITHHELD (≈90.2% support)
Both nominees were elected for three-year terms expiring at the 2028 Annual Meeting.
Proposal 2 – Authorization to Issue Shares Below NAV: Shareholders approved permitting the Board to sell or issue up to 25 % of outstanding common stock at prices below the then-current net asset value (NAV) per share.
- All shareholders: 11,161,327 FOR (≈70.2%), 3,306,930 AGAINST, 718,771 ABSTAIN
- Non-affiliate shareholders: 10,028,907 FOR, 3,306,930 AGAINST, 718,771 ABSTAIN
The authorization provides the company with added financing flexibility typical for Business Development Companies (BDCs) but could be dilutive if executed.
No other matters were brought before the meeting, and no financial performance data were presented in this filing.